We've got a hot batch of stocks to watch in the coming week. Make space on your watchlist for these high-potential, high-conviction tickers:
-
Amneal Pharmaceuticals Inc (AMRX) — Biosimilar play targets 53% upside on Strong Buy consensus.
-
Brink's Co (BCO) — Security giant eyes 55% upside with 200% return on equity.
-
Levi Strauss & Co (LEVI) — Iconic denim brand poised for 56% upside transformation.
-
Mntn Inc (MNTN) — Ad-tech disruptor targets jaw-dropping 211% upside surge.
-
Workiva Inc (WK) — Compliance SaaS targets 63% upside on 1,137% earnings surge.
-
PaySign (PAYS) — Fintech disruptor eyes 59% upside on 51% growth surge.
A note from our sponsors...
Windfall Profit Potential For These 5 Summer Stocks
From peak travel demand to the World Cup to home improvement season, summer drives the business behind each of these 5 companies. This free report covers the catalysts, fundamentals and analyst price targets.
Click here to access your free copy.
It’s back on the list! Workiva Incorporated provides cloud-based compliance and regulatory reporting solutions for businesses in the U.S. and internationally. The company is positioned as an excellent value choice in the software sector with strong earnings acceleration, forecasting remarkable EPS growth of +1,137.79% year-over-year to $2.97, while maintaining consistent revenue growth of 15.6% annually.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $50.02 — get current quote
Max 1-year forecast: $90.00
Why we're watching:
- Analyst support: 4 analysts cover WK with 3 Strong Buy ratings and 1 Buy rating, delivering a consensus average price target of $80.25 (+62.68% upside). See the ratings
- Stifel Nicolaus' Brad Reback (a top 15% rated analyst) recently maintained their Strong Buy rating with a $65.00 price target (+29.95% upside). The analyst community remains confident in Workiva's growth trajectory in the cloud-based compliance solutions market.
- Explosive earnings growth: Analysts forecast EPS to surge from $0.24 to $2.97 in one year (+1,137.79% growth), reaching $4.67 in three years, significantly outpacing the App industry average of 35.03% earnings growth.
- Strong revenue momentum: The company is projected to grow revenue from $925.6M to $1.1B (+15.6% growth), with consistent double-digit expansion through 2028, supported by increasing demand for regulatory compliance solutions.
- Industry ranking context: WK is currently the 5th highest-rated stock in the App industry, which has an Industry Rating of B.
- Zen Rating highlights: WK earns an overall Zen Rating of A, which amounts to a Strong Buy recommendation. Stocks with this rating have historically delivered market-beating returns.
- Component Grades: Among the Component Grades that shape the overall rating, the company excels particularly in Growth (A) with additional strength in Sentiment (B), Financials (B), and Artificial Intelligence (B). See all 7 Zen Component Grades here
The Brink's Company is a leading global security and protection company, best known for its bullet-resistant armored trucks providing security services to banks, retailers, governments, and mints worldwide. The company is projecting strong free cash flow growth with a 12% CAGR through FY 2030 and segment revenue growth at a 13% CAGR, driven by expanding incentive compensation systems linked to segment performance.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: Get current quote
Max 1-year forecast: $163.00
Why we're watching:
- Analyst support: Both analysts covering BCO rate it Strong Buy, with consensus price targets pointing to significant upside potential of 50% or more. See the ratings
- Truist Securities' Tobey Sommer (a top 14% rated analyst) recently maintained their Strong Buy rating with a $163.00 price target (+55.55% upside). Sommer noted that the company's free cash flow is expected to rise at a 12% CAGR through FY 2030, with segment revenue growing at a 13% CAGR, driven by expanding incentive compensation systems linked to segment growth.
- Financial strength: BCO demonstrates exceptional return on equity of 200.5%, significantly outpacing both the Security & Protection Service industry average of 50.45% and the broader market average of 147.3%.
- Earnings acceleration: Analysts forecast remarkable EPS growth of +116.53% year-over-year to $9.33, with current EPS at $4.31, reflecting strong operational momentum and market share gains.
- Industry ranking context: BCO is currently the #1 highest-rated stock in the Security & Protection Service industry, which has an Industry Rating of B.
-
Zen Rating highlights: BCO ranks in the top 5% of stocks we track based on a 115-factor fundamental review, earning an overall Zen Rating of A, which amounts to a Strong Buy recommendation.
- Component Grades: The company excels with an A grade in Safety and B grades in Value, Growth, and Sentiment, demonstrating well-rounded investment appeal across multiple factors. See all 7 Zen Component Grades here
3- Amneal Pharmaceuticals (NASDAQ: AMRX)
Amneal Pharmaceuticals is a specialty and generic pharmaceutical company developing and manufacturing products across various dosage forms and therapeutic areas. The company is accelerating its biosimilar efforts and positioning itself to close the valuation gap with industry peers, with strong Q1 2026 earnings driving increased confidence in its FY 2026 setup.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $12.00 — get current quote
Max 1-year forecast: $19.00
Why we're watching:
- Analyst support: All 3 analysts covering AMRX rate it Strong Buy, reflecting unanimous bullish sentiment on the company's biosimilar strategy and growth trajectory. See the ratings
- For example, UBS researcher Ashwani Verma (a top 11% rated analyst) recently initiated coverage with a Strong Buy rating and $19.00 price target, representing potential upside of +52.98%.
- It’s our Stock of the Week: Our Zen Investor Editor-in-Chief, Steve Reitmeister, is fully on board with the bullish case for AMRX. See his recent commentary here.
- Earnings momentum: The company delivered strong Q1 2026 results with analysts forecasting EPS growth of +158.92% year-over-year to reach $1.01, significantly outpacing the pharmaceutical industry average of 15.37% earnings growth.
- Industry ranking context: AMRX is currently the 5th highest-rated stock in the Pharmaceutical industry, which has an Industry Rating of B.
- Zen Rating highlights: AMRX is part of our top-rated tier of stocks, earning an A Zen Rating, which is equivalent to a Strong Buy recommendation.
- Component Grades: Each Zen Rating is composed of 7 Component Grades. The company demonstrates solid fundamentals across key metrics including Value (B), Sentiment (B), and Safety (B), positioning it well for continued upside. See all 7 Zen Component Grades here
Mntn Inc provides performance-driven TV solutions, offering innovative advertising technology platforms. The company shows exceptional upside potential with analyst price targets averaging $20.71 (+138.92% from current levels), supported by strong financial health including a low debt-to-equity ratio of 0.18 and robust projected earnings growth of +146.47% year-over-year.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $8.14 — get current quote
Max 1-year forecast: $27.00
Why we're watching:
- Analyst support: 7 analysts cover MNTN with 4 Strong Buy ratings, 2 Buy ratings, and 1 Hold rating, delivering a consensus average price target of $20.71 (about 140% upside), with the max forecast at $27.00 (over 200% upside). See the ratings
- Citizens' Andrew Boone (a top 5% rated analyst) recently maintained their Buy rating with a $19.00 price target (+130% upside). Boone believes Mntn shows strong growth potential and its market strategies will lead to customer retention, with the CEO focusing on expanding digital presence and enhancing user experience.
- Explosive earnings trajectory: Analysts forecast EPS to increase from $0.38 to $0.94 (+146.47% growth), reaching $1.44 in three years, while revenue is projected to grow from current levels to $358.8M (+19.9% growth) with continued acceleration.
- Strong financial foundation: The company maintains exceptional financial health with a debt-to-equity ratio of just 0.18, providing substantial flexibility for growth investments and strategic initiatives.
- Industry ranking context: MNTN is currently the 10th highest-rated stock in the App industry, which has an Industry Rating of B.
- Zen Rating highlights: Strong Buy (A) stocks have historically delivered returns higher than the S&P. MNTN is part of this elite tier of stocks.
- Component Grades: The company stands out with exceptional A grades in Value and Financials, complemented by B grades in Safety and AI, reflecting a combination of attractive valuation and strong operational execution. See all 7 Zen Component Grades here
PaySign, Inc. provides prepaid card products and processing services under the PaySign brand for corporate, consumer, and government applications. The company is experiencing remarkable growth driven by its patient affordability solutions, which delivered 51% revenue growth in Q1 2026 with significant margin expansion.
Zen Rating: Strong Buy (A) — see full analysis
Recent Price: $6.34 — get current quote
Max 1-year forecast: $11.00
Why we're watching:
- Analyst support: Strong consensus with 2 Strong Buy ratings from 2 analysts, with an average price target of $10.00 representing +44.51% upside. See the ratings
- Lake Street's Jacob Stephan (a top 18% rated analyst) maintains a Strong Buy with an $11.00 price target (+58.96% upside), noting that Q1 results beat expectations with 45.8% revenue growth year-over-year and arguing that "Paysign's fundamental inflection is still in the early innings."
- DA Davidson's Peter Heckmann (a top 14% rated analyst) maintains Strong Buy with a $9.00 target following Q1 2026 earnings that showed $22.76M in revenue and FY guidance of $106.5M to $110.5M.
- Industry ranking context: PAYS is currently the 3rd highest-rated stock in the Software Infrastructure industry, which has an Industry Rating of B.
- Zen Rating highlights: PAYS passed our rigorous fundamental review with great scores — earning it an overall A rating, which amounts to a Strong Buy recommendation.
- Component Grades: Looking at the Component Grades that shape that rating, PAYS earns an outstanding grade for Sentiment, with above-average marks for Growth, Financials, and our AI Factor review. Not bad. See all 7 Zen Component Grades here
What to Do Next?